Loading clinical trials...
Loading clinical trials...
Evaluating a Novel, Self-administered Device ("Flicker-App") That Measures Critical Flicker Frequency as a Test for Minimal Hepatic Encephalopathy in Cirrhosis
Conditions
Interventions
Critical flicker frequency
Locations
1
United States
University of Washington Medical Center
Seattle, Washington, United States
Start Date
October 22, 2019
Primary Completion Date
May 31, 2023
Completion Date
June 30, 2023
Last Updated
January 11, 2022
NCT06052176
NCT04073290
NCT04014413
NCT06368895
NCT03420482
NCT06987968
Lead Sponsor
University of Washington
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions